DrugBiological
Hepatitis B hyperimmune globulin clinical trials
Also written HBIG.
Includes 2 studies of BT088 immunoglobulin, human.
- studies test it
- 13
- open now
- 2
- in phase 3
- 3
- first study started
- 1999
Keep track of what changes. Save the hepatitis B hyperimmune globulin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
- HBIG
- 3
Combined with it in one product
Studies by the year they started
13 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 3
- Phase 4
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 6
Biotest Pharmaceuticals Corporation (1) · GlaxoSmithKline (1) · Instituto Grifols, S.A. (1) · SK Chemicals Co., Ltd. (1) · Biotest (1) · Xi'an Jiaotong University (1) · Gilead Sciences (1) · Cangene Corporation (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses hepatitis B hyperimmune globulin is read from its arms, and is right about nine times in ten.
Testing it · 13
- Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis BRecruitingEarly Phase 1Peking University People's HospitalNCT07328711Written as Hepatitis B Immunoglobulin (HBIg)
- Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV DonorsRecruitingPhase 4University Health Network, TorontoNCT07189377Written as HBIG
- Treatment of Patients With Chronic Hepatitis B With Hepatitis B ImmunoglobulinsTerminatedPhase 2Hannover Medical SchoolNCT05345990Written as Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT03575208Written as hepatitis B immune globulin (HBIg)
- Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver TransplantationCompletedPhase 1/2Biotest Pharmaceuticals CorporationNCT01421212Written as Hepatitis B Immune Globulin (Boca HBVIg)
- LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ MothersCompletedPhase 4GlaxoSmithKlineNCT00240526Written as Hepatitis B immunoglobulin (HBIg)
- Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant RecipientsCompletedPhase 3Instituto Grifols, S.A.NCT01131065Written as Hepatitis B immune globulin
- A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation RecipientsCompletedPhase 3SK Chemicals Co., Ltd.NCT01513850Written as Hepabulin IV
- A Clinical Trial of Zutectra in Patients Who Recently Received a Liver TransplantCompletedPhase 3BiotestNCT01856413Written as Zutectra
- Prevention for Mother-to-infant Transmission of HBVCompletedNot applicableXi'an Jiaotong UniversityNCT02312531Written as Hepatitis B immunoglobulin
- Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver TransplantCompletedPhase 2Gilead SciencesNCT00507689Written as Hepatitis B Immunoglobulin (HBIg)
- Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant PatientsCompletedPhase 4Cangene CorporationNCT00722332Written as HepaGam B
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ MothersCompletedNot applicableGovind Ballabh Pant HospitalNCT01412567Written as Vaccine+HBIG
Codes
What other systems call hepatitis B hyperimmune globulin · ClinicalTrials.gg INT003207
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C045213 | hepatitis B hyperimmune globulin | One source NLM |
| RxNorm | 26744 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.